Journal of Heart and Lung Transplantation

Article	Citations
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation	552
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial	269
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients	176
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant	121
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing	105
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation	103
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass	103
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy	85
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients	85
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil	79
Early Onset Malignancy in the First-Year After Heart Transplantation	75
WITHDRAWN	68
Older Donor Hearts for Heart Transplantation	68
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension	67
Comparative Analysis of Fontan Transplant Outcomes	65
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report	64
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes	63
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD	60
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation	59
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience	59
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients	58
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade	57
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients	54
Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status	53
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome	53

Utility of Breath Volatomic Analysis in Lung Transplant Recipients	51
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD	51
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models	49
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation	48
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis	48
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience	47
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion	47
INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION:EVOLUTION OF PROGNOSIS IN 10 YEARS OF NEW EMERGING THERAPIES	43
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation	42
MINIMALLY INVASIVE PULMONARY ENDARTERECTOMY THROUGH INVERTED-T UPPER HEMISTERNOTOMY	42
Exercise Test and Hemodynamic Outcomes in Heart Transplant Patients Treated with Long-Term Mechanical Circulatory Support as Bridge to Transplantation	41
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial	41
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients	41
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis	40
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation	39
Cardiac Tamponade Associated to an Early EBV-Induced Lymphoma After Heart Transplantation: A Case Report	37
Living-Donor Single-Lobe Lung Transplantation: A Single-Center Case Series	37
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support	37
Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Acute Decompensated Heart Failure	36
Extending the bridge, bridging the gap	36
First North American Experience with The Berlin Heart Active Driver	36
Mollicute Infections in Lung Transplant Patients: A Retrospective Review of Recipient Infections Post Initiation of a Screening Protocol	35
Global Outcomes with Extended Criteria Donors When Preserved at 4-8°C: An Updated Analysis of the International GUARDIAN Heart Registry	35
Outcomes in Children Supported with Paracorporeal Continuous Compared to Paracorporeal Pulsatile Ventricular Assist Devices	34
Conversion from Immediate Release Tacrolimus to LCP-Tacrolimus in Heart Transplant Recipients	34
Outcomes After Heart Transplantation from Donors After Circulatory Death versus Brain Death: A Systematic Review and Meta-Analysis	33
Immunologic Outcomes Following Mycophenolate Dose Reduction in Lung Transplant Recipients	33
Letermovir Use for Cytomegalovirus Prophylaxis in Lung Transplant Recipients	33
Early Outcomes from the Use of Thoracic Epidural Analgesia versus INC Cryoablation during Lung Transplantation - A Single Center Experience	32
The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients	32
SRC Homology and Collagen (Shc) Inhibition: A Novel Therapeutic Strategy for Transplant-Related Pulmonary Fibrosis	32
Sternal Closure After Clamshell Thoracotomy for Bilateral Lung Transplantation: Comparison Between Different Techniques	30
Pharmacist Managed Timing of Peri-Operative Plasmapheresis and Anti-Thymocyte Globulin in Heart Transplantation	30
Acute Myocarditis: Trying to Dissect Potential Prognostic Factors	30
Post Transplant Malignancy Risk Factors in Thoracic Solid Organ Transplant Recipients	29
Impact of Donor Transfusions on Lung Transplant Outcomes: A National Cohort Analysis	29
An Uncommon Driver of Waitlist Urgency: Recurrent Secondary Spontaneous Pneumothoraces of the Lung Allograft in a Single Lung Transplant (SLT) Recipient with CLAD	29
Single Nuclei Transcriptomic Analysis of Heart Allograft Ischemia-Reperfusion in a Rat Model	28
A Bold Look: Evaluation of Skeletal Muscle Microvascular Function in Pediatric Heart Transplant Recipients Using Post-Contractile Blood Oxygen Level Dependent MRI	28
Activation of cGAS-Dependent Necroptosis during Cold Static Preservation of Lungs Relies on Calcium	28
Influence of Risk Factors on PTLD-Free Probability in Lung Transplant Patients: SRTR Database Analysis	28
A Single Centre Review of INR Monitoring in Patients Implanted with HeartMate 3 Ventricular Assist Device	28
Use of Heart in Donor Death Caused by Lightning	28
End Stage Heart Failure in Systemic Sclerosis- From Mechanical Circulatory Support to Heart Transplant	28
Information for Readers	27
Effect of Heparin Coated ECMO Circuit on AntiPF4 Antibodies	27
Information for Readers	27
Donor Factors Contributing to the Increase in Adult Heart Transplant Volume in the United States	27
Evaluating age-based eligibility thresholds for heart re-transplantation – an analysis of the united network for organ sharing database	27
Midterm Outcomes in Orthotopic Heart Transplant Recipients with a History of Methamphetamine Use	27

Table of Contents	26
(911) Older Donors in Lung Transplantation: The Portuguese Experience	26
Alveolar macrophage subsets: Accessories to lung alloimmune rejection	26
(904) Early Weight Gain During Ex Vivo Lung Perfusion Can Predict Transplant Suitability and Post-Transplant Outcomes	26
(742) Prognostic Value of Donor Specific Human Leukocyte Antibodies in Pre-Sensitized Heart Transplant Patients	25
(120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience	25
(811) Incidence of Right Ventricular Dysfunction in Lvad Patients Bridged with High Dose Inotropes	25
(908) Does Donor-Recipient Sex Mismatch Have an Influence on Long Term Outcomes after Lung Transplantation? An Experience of a High Volume Center	25
(1215) Think Inside The Box: Constrictive Pericarditis after Pediatric Lung Transplant	25
(849) The Utility of Mechanical Circulatory Support in the Management of Massive Pulmonary Embolism with Right Ventricular Failure	25
(1206) Clinical Implications of Microbiome on Acute Rejection in Lung Transplant Recipients	24
(797) Implantation from Short Term MCS to Durable VAD: Single Center Experience	24
(384) Urine Exosomes for Kidney Health Assessment in Mechanical Circulatory Support	24
(1188) Assessment of Dd-cfDNA Between Stable Single and Double Lung Recipients	24
(1226) Serum Proteomics for Fibrotic Markers in Early Detection of Bronchiolitis Obliterans Syndrome after Lung Transplantation	24
ISHLT 2023 Author Index	24
(151) Plasma Proteomic Signature of Human Heart Transplant Recipients After Restoration of Blood Circulation and Its Relationship to Graft Outcome	24
Recurrence of pulmonary arterial hypertension 32 months after bilateral lung transplant	23
(715) Diaphragm Dysfunction from Covid-19 Phrenic Neuropathy: Utilization of Diaphragm Pacing for Recovery	23
(854) Effect of Dobutamine on Rv Contractility and Rv-Pa Coupling in the Normal Rv	23
Extra-cardiac management of cardiogenic shock in the intensive care unit	23
(1153) Characterization of CD3-Guided Anti-Thymocyte Globulin Dose Minimization for Renal Sparing Induction after Heart Transplant	23
(1270) Thermal Preconditioning During EVLP Reduces T Lymphocytes and Increases Monocytes and Neutrophils Contents in the Perfusion Solution	23
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection	23
(1033) Effect of Practice Variation Amongst Organ Procurement Organizations on Pediatric Donor Heart Utilization	23
(472) Giant Cell Myocarditis with LVAD Presenting with Acute Severe AI Managed with Valve-In-Valve TAVI	23
(324) Stanford Pediatric Psychosocial Optimization Tool for Transplant	23
Lung Transplantation for Primary Ciliary Dyskinesia - A Single Center Review	22
Optimizing the handling of missing data in the UNOS database	22
Functional status predicts pediatric heart transplant outcomes: A united network for organ sharing (UNOS) database study	22
Improved Oxygenation and Atelectasis in Brain-Dead (BD) Donors with a Novel Percutaneous Transvenous Phrenic Nerve Stimulator	22
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation	22
Backwash Maneuver in LVAD Inflow Thrombosis: A Single-Center Experience (2015-2024)	22
Extended Hypothermic Cardiac Preservation Using the VP.S ENCORE® Device Leads to Enhanced Cardiac Function in a Pilot Orthotopic Porcine Heart Transplant Study	22
Cold Blood Cardioplegia Use for Cardiac Arrest After Heart Transportation with Organ Care System May Improve Outcomes	21
Duration of Donor Cardiac Downtime in Donors After Circulatory Death Transplant	21
Social Determinants of Health, Race and Their Relationship to Time in Therapeutic INR Range Following LVAD Implantation	21
New Rules, Improved Results: Successful Outcomes Bridging Patients Listed Status 1 for Heart Transplantation	21
Comparing the Outcomes of Combined Heart-Liver Transplant Recipients from DCD and Non-DCD Donors: An Analysis Using the UNOS Database	21
Impact of Logistic Challenges on Cardiac Transplantation	21
Survival After Combined Lung and Liver Transplantation: A 22-year Single-Centre Retrospective Study	21
Letter to the Editor: Can the grading of mild cardiac allograft vasculopathy be further refined? An angiographic and physiologic assessment of heart transplant recipients with ISHLT CAV 1	20
Pulmonary artery fresh floating thrombus in patients with chronic thromboembolic pulmonary hypertension on low-dose direct oral anticoagulants: A single-center angiographic observational study	20
DCD heart transplantation with NRP: Excellent results and a continued uphill battle	20
Enhancing Post-Lung Transplant Care with AlloHome: Early Impact Evaluation	20
Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantation	20
Early Detection of Baseline Lung Allograft Dysfunction: The Concept of Pre-BLAD	20
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis	20
Ex-vivo lung perfusion: National trends and post-transplant outcomes	19
Pediatric Heart Transplantation in Donation After Circulatory Death Using Normothermic Regional Perfusion - Early Experience with Small Donors	19
Information for Readers	19
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System	19
Metabolic vulnerability and opportunity in donation after circulatory death heart transplantation: Oxygen extraction ratio as a physiologic bridge between donor injury and recipient outcomes	19
(888) Initiating an ECMO Program at a Safety Net Hospital During a Global Pandemic	19
Differential transcriptomic and metabolomic landscape between human hearts donated after cardiac vs brain death	19
Metabolomic signature of right ventricular–pulmonary arterial coupling differentiates hemodynamic response to imatinib therapy in pulmonary arterial hypertension	19
The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients	19
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients	19
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection	19
Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: A retrospective cohort study	19
A rare case of late onset tacrolimus-induced leukoencephalopathy and coma after pediatric orthotopic heart transplantation	19
Re-evaluating ischemic tolerance and prognostic accuracy in DCD cardiac transplantation: A critical appraisal of taNRP outcomes	19
Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing	19
Center volume effect on acute cellular rejection and outcomes in pediatric lung transplant recipients	19
MTHFD2 ablation in T cells protects against heart transplant rejection by perturbing IRF4/PD-1 pathway through the metabolic-epigenetic nexus	18
(782) Use of Extracorporeal Membrane Oxygenation in Ranolazine Overdose	18
Use of a Novel Risk Score (MARKER-HF) to Predict Outcomes After Heart Transplant	18
Optical-Flow Analysis Demonstrates Preserved Contractility and In-Vivo Function After 24-Hour of Hypothermic Oxygenated Perfusion in Porcine Hearts	18
Multilayer Networks Reveal Centrality Rewiring in Heart Transplant Rejection and Infection	18
“Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World”	18
Towards a Paradigm Shift in Cystic Fibrosis Lung Transplantation: Re-Transplantation Era	18
Heart Failure Phenotypes and Outcomes After TAVR vs SAVR: A Trinetx Database Analysis	18
Efficacy and Safety of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy After Heart Transplant (ACAV Trial, NCT04193306)	18
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion	18
Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study	18
Organ Care System (OCS) Perfusion Time During Donation After Circulatory Death (DCD) Heart Transplantation: Not Too Little, Not Too Much: There Safety Lie	18
Ischemia-Reperfusion Injury (IRI) Drives Epithelial and Endothelial Cell-Surface GRP78 (csGRP78) Expression and Anti-GRP78 Humoral Autoimmunity in a Mouse Lung Transplant (LTx) Model of Chronic Lung A	18
Urinary Cell Cycle Arrest Biomarkers for the Early Prediction of Acute Kidney Injury After Lung Transplantation	17
Personalized Platelet Inhibition on Paracorporeal Ventricular Assist Device Support: Single-Center Experience with Pediatric Pharmacogenomic Testing	17
Isolated Plasma Rich Liver Rejection in Combined Heart-Liver Transplant	17

10°C Storage Preserves Metabolic Reserve and Reduces Oxygen Debt in Heart Transplantation	17
Impact of Low Donor/Recipient Predicted Heart Mass Ratio on PGD and Survival: A Report from the Organ Heart Perfusion Registry	17
Bletilla Striata Polysaccharide Attenuates Ischemia-Reperfusion Injury After Lung Transplantation in Rats by Inhibiting NLRP3-Mediated Pyroptosis	17
How to Stratify Cardiovascular (CV) Prognosis in Heart Transplanted (HT) Patients: Do Tools of the General Population Work?	17
Establishing Australia’s First Paediatric DCD Heart Transplant Program	16
The Impact of Intraoperative Hypothermia on Surgical Site Infections in Pediatric Heart Transplant	16
A Comparison of Postoperative Hemodynamic Trajectories in Donation After Brain Death versus Circulatory Death Heart Transplantation	16
Single-Nuclei Transcriptomic Atlas of Chronic Lung Allograft Dysfunction Reveals Distinct Molecular and Cellular Signatures in BOS and RAS	16
Viscoelastic Tests Did Not Reduce Transfusion During Lung Transplantation	16
A Novel Risk Score for Right Heart Failure Following Contemporary LVAD Implants	16
Effect of GLP1-Receptor Agonist Therapies for Patients with a LVAD and Obesity: A Case Series	16
A Cellular Single-Nucleus RNA Atlas of the Chronic Lung Allograft Dysfunction Spectrum from Small Airway Disease to Parenchymal Fibrosis	16
Machine Learning Leads To Earlier, Real-time Predictions Of Lung Transplant Acceptance During rc-EVLP	16
Only Time Will Tell: Early versus Delayed Tacrolimus Initiation in Heart Transplant Recipients without Induction	16
Diagnostic Performance of Donor-Derived Cell-Free DNA After Conversion to Sirolimus in Heart Transplant Recipients	16
Hospital Length of Stay After Heart Transplantation with Durable or Temporary Mechanical Circulatory Support	16
Tick Tock Goes the Clock: Normothermic Machine Perfusion versus Static Cold Storage at 10°C for Extended Preservation of Cardiac Allografts	16
Using CMR to Diagnose Acute Graft Rejection Post Heart Transplant: Case Report	16
Use of Controlled Hypothermic Lung Preservation to Optimize Outcomes in Older Recipients	16
Dynamic dd-cfDNA Levels and Risk of Cardiac Allograft Dysfunction: A Time-Varying Cox Analysis	15
Transcriptomic Profiling of Donor-Heart Tissue Across Organ Procurement Modalities	15
Defining Patient-Specific Baseline Donor-Derived Cell-Free DNA in Lung Transplantation	15
Donor Derived cfDNA% Kinetic Patterns are Associated with Longitudinal Spirometry Trajectory After Lung Transplantation	15
Achieving Safe and Equitable Access to Heart Transplantation in Recipients with HIV: A Contemporary National Study	15
Contemporary outcomes of mechanical circulatory support using paracorporeal continuous flow pump in children: A report from the ACTION learning network	15
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure	15
Quality of Life and Decision Regret After Left Ventricular Assist Device Implantation: Insights from the Distressed Community Index	15
Improvement in 2 Year Outcomes with the SherpaPak Cardiac Transport System: A Large, Single-Center Experience	15
Renal Outcomes in Cardiogenic Shock Managed with Impella 5.5 as a Bridge to Orthotopic Heart Transplant	15
Recipient Risk Stratification Using Index for Mortality Prediction After Cardiac Transplantation (IMPACT) Score in DCD Cohort	15
Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection	15
Right Ventricular Failure in a Patient with LVAD Confounded by CardioMEMS Readings: A Case Report	15
A signal that hypothermia reduces inflammation during donor heart preservation, and a reminder that large animal models remain vital to the development of iterative improvements in myocardial preserva	15
Quadruple Immunosuppression in a Patient with Persistent Donor Specific Antibodies: When is It Time to Consider Other Therapies?	15
A Novel Risk Score for 1-Year Mortality Following Donation After Circulatory Death Heart Transplantation	15
Investigating Vectorcardiography as a Marker of Myocardial Remodeling in Patients Supported by Left Ventricular Assist Devices	15
Donor Coronary Artery Disease Does Not Adversely Affect 1-Year Survival After DCD Heart Transplant: A UNOS Database Analysis	15
Why LVAD use is stagnant: A failure of diffusion and a path forward	15
Impact of coronary hypoperfusion during agonal phase on outcomes following donation after circulatory death heart transplantation	14
Towards a nuanced understanding of donor risk	14
WITHDRAWN	14
Microcirculation as a Predictor of Clinical Outcomes in Left Ventricular Assist Device Therapy	14
Kratom Toxicity: A Mimicker of Fulminant Myocarditis	14
Early Rejection and Graft Vasculopathy in DCD Hearts: A Comparison of Recovery Methods	14
Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes	14
Cardiac output assessment methods in left ventricular assist device patients: A problem of heteroscedasticity	14
Table of Contents	14
Taking a second chance: Unlocking myocardial recovery after left ventricular assist device support	14
Combination Approach of Perioperative Plasmapheresis and Eculizumab for Highly Sensitized Lung Transplant Patients	14
Initial Analysis of Immune Phenotypes in Heart Transplant Recipients of the ALL IN HEART (Tocilizumab) Trial	14
Current Global Trends and Challenges Utilizing Pediatric Ventricular Assist Devices: An Action Collaborative Survey	14
Response to “Early post lung transplant neutrophil dynamics within 72 hours”	14
Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheep	14
Shock Teams Grow Volume and Improve Outcomes in Cardiogenic Shock	14
Does Donor-Recipient Age Mismatch Affect Long-Term Immunological Outcomes? A 10-Year Single Center Study	14
Durable Ventricular Assist Device Support with Systemic Right Ventricle Cannulation	14
Evaluating Postoperative Outcomes of Heart Transplant Recipients from Active COVID19 Positive and Negative Donors Using Induction Therapy	14
Improving Efficiency in Pharmacist Led Thoracic Transplant Patient Medication Education	13
Gut Reaction: Gastroesophageal Reflux Fuels De Novo DSA Development After Lung Transplant	13
Application of Optical Mapping for Assessing Ischemic Regions in Donor Hearts: A Novel Approach to Monitoring Action Potential Hysteresis and Triangulation	13
Left Ventricular Stenting - A Novel Technique for LVAD Implantation in Patients with Restrictive Cardiomyopathy	13
Hemodynamics at Submaximal Exercise Independently Predict Outcomes in Severe Heart Failure	13
Long-Term Outcomes of Ventricular Assist Devices in Obese Pediatric Patients: An ACTION Registry Study	13
Differences in Prevention, Diagnosis, Surveillance and Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Patients: Results of an International Survey	13
Impact of Preoperative Opioid Use in Lung Transplant Recipients	13
Plasmablastic Lymphoma in a Lung Transplant Recipient	13
A Rare Case of HeartMate 3 Pump Stoppage	13
Reversion of Val(ganciclovir)-Resistance Associated Mutation in Two SOT Patients with Mismatch Serostatus for CMV (D+/R-)	13
MHC Class II Matching Does Not Predict Survival in Organ and Bone Marrow Transplantation in Non-Human Primates	13
Tuberculosis Post Lung Transplantation - An Indian Experience	13
Porcine Mitochondria Transplantation in Human iPS-Cardiomyocytes and Intact Hearts	13
Patients with Acute Lung Rejection Have a Worse Outcome After Combined Heart-Lung Transplantation	13
ADAM10-Mediated VE-Cadherin Shedding May Increase the Risk of Sepsis for Heart Failure Patients Supported by Continuous-Flow Left Ventricular Assist Devices	12
First Sub-Zero Cardiac Allograft Preservation and Reanimation Following 24-Hours of Isochoric Supercooled Preservation	12
Use and Outcomes of Ex-Vivo Machine Perfusion (EVMP) in Donation After Brain Death (DBD) Heart Transplantation (HT)	12
CD38 Antibody Daratumumab as an Add-On Rescue Therapy for AMR - First Report in Clinical Lung Transplantation	12
Donor sequence number is not associated with worse lung transplant outcomes regardless of transplant center case volume	12
The future of durable mechanical circulatory support devices: Emerging innovations	12
Impact of evolocumab on coronary physiology and microstructure in de-novo heart transplant recipients	12
Does Gastrointestinal Bleeding Increase the Risk of Thromboembolic Events in Patients Supported with CF-LVADs?	12
Use of Newer Intravascular Microaxial Ambulatory Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock in Adult Congenital Heart Disease Patients	12
Non-Ischemic Preservation of the Donor Heart in Heart Transplantation - A Randomized, Controlled, Multicenter Trial Using The Xvivo Heart Assist Preservation System for Hypothermic Oxygenated Perfusio	12
Dapagliflozin Use in Children with Heart Failure Undergoing Heart Transplantation	12
Outcomes of Explanted LVAD Patients with Heart Failure Relapse Requiring Heart Replacement Therapies: A VAD Wean Registry Analysis	12
SAFETY OF BALLOON PULMONARY ANGIOPLASTY IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	12
The Impact of Functional Warm Ischemia Time on Procurement and Preservation Technique in DCD Heart Transplantation	12
Esophagogastric Junction (EGJ) Outflow Obstruction is Associated with Chronic Lung Allograft Dysfunction (CLAD)	12
Selection of lung transplant candidates: A pediatric perspective on the International Society for Heart and Lung Transplantation consensus document	12
Donor Heart Preservation at 4-8°C Using Moderate Hypothermic Donor Heart Preservation Improves 4-year Survival in the US Guardian-Heart Registry	12
Lung Ultrasound for Diagnosis of Primary Graft Dysfunction in Lung Transplantation Recipients	12
Donor-Derived Cell-Free DNA as a Biomarker for the Effect of Daratumumab in Patients with Antibody-Mediated Rejection Post-Heart Transplant	12
Digoxin Reverses Angiogenic Dysregulation During HeartMate 3 Support by Inhibiting the HIF1-a Signaling Cascade and is Associated with Decreased Risk for Gastrointestinal Bleeding	12
Triheptanoin Use for Severe Neonatal Cardiomyopathy Secondary to Mitochondrial Trifunctional Protein Deficiency- A First Report	11
Lung Transplantation in Patients with Hermansky-Pudlak Syndrome	11
Between Metrics and Measures: KCCQ, CPET, and HF Prognosis	11